Skip to main content
TU
NYSE Technology

TELUS Posts $660M Loss on $800M Health Impairment, Launches $900M Cost-Cut Program

Tom Rudovsky · Reported by PR Newswire
More coverage: Telecom Stocks · Communication
Sentiment info
Negative
Importance info
8
Price
$9.42
Mkt Cap
$14.968B
52W Low
$7.64
52W High
$14.95
52W Position info
23% above low
Off High info
37% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

TU sits 23% above its 52-week low of $7.64.

Summary

TELUS swung to a net loss of $660 million (basic loss per share $0.42) after booking an $800 million pre-tax non-cash goodwill impairment on TELUS Health, tied to reduced growth expectations and the active divestiture process. Adjusted net income fell 32% to $251 million and adjusted EPS dropped 33% to $0.16, while consolidated Adjusted EBITDA slipped 5% to $1.8 billion on weaker TELUS Digital volumes from two hyperscale clients. Free cash flow fell 35% to $396 million as capex rose 8% to $701 million. Management is leaning hard on the balance sheet fix: a new multi-year efficiency program targets roughly $900 million in annualized cash savings exiting 2028, with about 80% from core Telecom, and it is accelerating monetization of TELUS Health and TELUS Agriculture & Consumer Goods to pay down debt. The company raised its 2026 restructuring and other costs assumption to approximately $900 million from $500 million, with cash restructuring disbursements now estimated at approximately $650 million. Net debt to Adjusted EBITDA sits at 3.6-times against a 3.0-times target by year-end 2028, and full-year 2026 guidance was reaffirmed. The board added Marc Allera and Bill Thomas effective January 1, 2027, and declared a quarterly dividend of $0.1875 payable January 4, 2027. The 9:30 am ET conference call today will be the first read on how investors weigh the impairment and cost plan against the reaffirmed outlook.

Updated with an SEC 6-K filing · What changed

Updates

  1. · SEC 6-K — TELUS raised its 2026 restructuring and other costs assumption to approximately $900 million from $500 million, with cash restructuring disbursements now estimated at approximately $650 million.

At the time of this announcement, TU was trading at $9.42 on NYSE in the Technology sector, with a market capitalization of approximately $15B. The 52-week trading range was $7.64 to $14.95. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

TU - Latest Insights

TU
Nov 16, 2026, 4:44 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $9.80
Real-time Price: $10.81 info
Change: +$1.01 (+10%) info
Market Cap: $17.162B info
TU
Nov 16, 2026, 1:17 PM EST
Source: Benzinga
Importance Score:
9
Price at Filing: $9.44
Real-time Price: $10.81 info
Change: +$1.38 (+15%) info
Market Cap: $17.162B info
TU
Nov 06, 2026, 7:09 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.07
Real-time Price: $10.81 info
Change: +$1.74 (+19%) info
Market Cap: $17.162B info
TU
Jul 31, 2026, 7:12 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $9.81
Real-time Price: $10.81 info
Change: +$1.00 (+10%) info
Market Cap: $17.162B info
TU
Jul 31, 2026, 6:45 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $10.76
Real-time Price: $10.81 info
Change: +$0.050 (+0.46%) info
Market Cap: $17.162B info